Hypersensitivity. Increased pigmentation; eyelid skin darkening, eyelash changes. Inflammatory & neovascular glaucoma, inflammatory ocular conditions or congenital glaucoma; known predisposing risk factors for iritis/uveitis; in aphakic & pseudophakic patients w/ torn posterior lens cap or anterior chamber lenses, cystoid macular edema; intercurrent ocular conditions or ocular surgery; history or recurrent herpetic keratitis associated w/ prostaglandin analogues & active herpes simplex keratitis. Administer 5 min apart if >1 topical ophth is used. Remove contact lens prior to & reinsert 15 min after instillation. Avoid eye contact w/ container tip. Renal or hepatic impairment. Not to be used during pregnancy & lactation. Ped <1 yr & infants <36 wk gestation.